These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 17383209)
1. NT-proBNP, IGF-I and survival in patients with chronic heart failure. Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209 [TBL] [Abstract][Full Text] [Related]
2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure. Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477 [TBL] [Abstract][Full Text] [Related]
4. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center. Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021 [TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526 [TBL] [Abstract][Full Text] [Related]
6. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114 [TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772 [TBL] [Abstract][Full Text] [Related]
8. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency. Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774 [TBL] [Abstract][Full Text] [Related]
9. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome. Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure]. Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545 [TBL] [Abstract][Full Text] [Related]
11. Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure. Andreassen M; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Kristensen LØ; Faber J Growth Horm IGF Res; 2009 Dec; 19(6):486-90. PubMed ID: 19398211 [TBL] [Abstract][Full Text] [Related]
12. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. Bruch C; Rothenburger M; Gotzmann M; Sindermann J; Scheld HH; Breithardt G; Wichter T J Am Soc Echocardiogr; 2006 May; 19(5):522-8. PubMed ID: 16644435 [TBL] [Abstract][Full Text] [Related]
13. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Dong H; Chen DQ; Wang Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308 [TBL] [Abstract][Full Text] [Related]
15. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance]. Yang CL; Qiu YR; Zhou F; Feng PF Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223 [TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760 [TBL] [Abstract][Full Text] [Related]
17. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure. Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665 [TBL] [Abstract][Full Text] [Related]
18. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600 [TBL] [Abstract][Full Text] [Related]
19. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860 [TBL] [Abstract][Full Text] [Related]
20. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]